Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Sanofi, Eli Lilly, Novo Nordisk Dodge Another Insulin RICO Suit

April 1, 2020, 7:52 PM

Sanofi-Aventis US LLP, Eli Lilly & Co., and Novo Nordisk Inc. beat more racketeering claims over their alleged scheme to overcharge for insulin while paying insurers kickbacks to cover their interchangeable drugs, when a New Jersey federal judge dismissed most of a lawsuit by Minnesota’s attorney general.

Judge Brian R. Martinotti’s ruling left intact several state law claims, including for fraud and unjust enrichment, and gave Minnesota AG Keith Ellison permission to amend the racketeering allegations. It appears to line up with Martinotti’s February ruling in a parallel case, but the judge’s reasoning is currently under ...